Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-23

Clinical Trial Update: Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on safety and efficacy of Azzalure, Restylane/Emervel filler, and Restylane Skinbooster for facial aesthetic treatment; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azzalure
  • Restylane Skinbooster (hyaluronic acid filler for skin boosting)
  • Restylane/Emervel filler

Snippet

Sponsor: Galderma R&D | Conditions: Facial Aesthetic Treatment | Phase 4 | Status: COMPLETED | Results posted: 2019-09-23